Neuronetics, Inc. (STIM): Volume dana dhuwit perusahaan

Simbol resmi perusahaan NeuroStar (STIM)

Neuronetics, Inc. (STIM) systems ensure a steady cash flow due to the regularity of therapy sessions. This cash reserve chart demonstrates current liquidity, with the 0.03 mark serving as the current balance indicator. However, slow technology adoption and competition from pharmaceuticals are weighing on margins. Simultaneously, Neuronetics, Inc. (STIM) is reducing production waste and energy costs in compliance with ESG environmental standards.

Dana dhuwit perusahaan: Neuronetics, Inc (STIM) kanggo 04.07.2022 - 21.11.2026

Ringkesan rincian data analitis Neuronetics Inc. (STIM)

- kuotasi lan prakiraan analis:
Analisis wiwitan perusahaan:Neuronetics, Inc STIM
Produk merek Neuronetics

For the long-term investor, the financial stability of Neuronetics, Inc. (STIM) is determined by its ability to maintain liquidity amidst expansion. This metric captures the volume of available cash, allowing for an assessment of the company's net value and the elimination of hidden capital lock-up risks. The current cash balance stands at 0.03, reflecting the actual resources available for development. Global deliveries of equipment and software create a steady cash flow, guaranteeing the operational viability of the business.

Analisis perusahaan pesaing

Volume dana dhuwit perusahaan BSX|Dana dhuwit perusahaan EW (Edwards Lifesciences Corporation)|Dana dhuwit perusahaan ResMed RMD|Volume dana dhuwit perusahaan Insulet Corp PODD|ZBH: Dhuwit awis perusahaan|Sisa dhuwit perusahaan COO (CooperVision)|ALGN (Align Technology, Inc.) - Dhuwit awis perusahaan|Globus Medical, Inc. - Sisa dhuwit perusahaan|TMDX (TransMedics Group Inc) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alphatec Holdings ATEC|Dana dhuwit perusahaan CryoLife (AORT)|Enovis Corporation (ENOV) - Posisi dhuwit perusahaan|Integra LifeSciences Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Establishment Labs ESTA|Beta Bionics, Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan IRADIMED Corp IRMD|Embecta (EMBC) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan TNDM (Tandem Corp)|Dana dhuwit perusahaan axogeninc.com|Dhuwit awis perusahaan SI-BONE, Inc. (SIBN)|Volume dana dhuwit perusahaan OFIX|Bioventus Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan orthopediatrics.com KIDS|TMCI: Dhuwit awis lan setara dhuwit awis perusahaan|SRTA: Dhuwit awis perusahaan|Carlsmed Inc - Gunggung dana dhuwit perusahaan|RxSight (RXST) - Dana dhuwit perusahaan|Dhuwit awis perusahaan ClearPoint|Dhuwit awis perusahaan STXS|Sight Sciences, Inc (SGHT) - Aset likuid perusahaan|Volume dana dhuwit perusahaan OBIO|Aset likuid perusahaan Anika Therapeutics Inc.|Dana dhuwit perusahaan InspireMD, Inc. NSPR|Sisa dhuwit perusahaan ZJYL|VANI - Dana dhuwit perusahaan|Xtant Medical Holdings, Inc. - Gunggung dana dhuwit perusahaan|NeuroOne (NMTC) - Dana dhuwit perusahaan|Modular Med (MODD) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Myomo, Inc|Dhuwit awis perusahaan Envoy Medical (COCH)|Volume dana dhuwit perusahaan VVOS|NVNO (enVVeno Corp) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SINT (Sintx Technologies)|TNON: Dhuwit awis lan setara dhuwit awis perusahaan|Lifeward - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AMIX (Autonomix Medical)|IVF: Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan Bone Biologics Corporation BBLG|Dhuwit awis perusahaan AXNX|BIOLASE, Inc. (BIOL) - Aset likuid perusahaan|Volume dana dhuwit perusahaan DYNT|Aset likuid perusahaan Paragon 28|Volume dana dhuwit perusahaan INVO (INVO Bioscience, Inc.)